Liang Liu

机构：Shanghai Jiao Tong University, Hefei University, Shanghai Clinical Research Center, Wake Forest University · ORCID：0000-0001-8630-7430

发表论文 226 篇 · 总被引 5283 次 · h-index 37

代表论文

• A nuclear RNA degradation code is recognized by PAXT for eukaryotic transcriptome surveillance (2025 · Molecular Cell · 被引 30)
• The Crosstalk with CXCL10‐Rich Tumor‐Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape (2025 · Advanced Science · 被引 17)
• Remote ischaemic conditioning improves outcomes of ischaemic stroke treated by endovascular thrombectomy: the SERIC-EVT trial (2025 · European Heart Journal · 被引 13)
• Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma (2025 · Blood · 被引 10)
• Subtypes of tumor-associated neutrophils and their roles in cancer immunotherapy (2025 · Critical Reviews in Oncology/Hematology · 被引 6)
• Efficacy and safety of cafelkibart (LM-108), an anti-CCR8 monoclonal antibody, in combination with anti-PD-1 therapy in patients with pancreatic cancer: Results from phase 1/2 studies. (2025 · Journal of Clinical Oncology · 被引 5)